| Overview |
| bsm-2000M-APC-Cy5.5 |
| HBcAg (1H8) Monoclonal Antibody, APC-Cy5.5 Conjugated |
| IF(IHC-P) |
| Virus, Others |
| Specifications |
| APC-Cy5.5 |
| Mouse |
| Recombinant Hepatitis B Core Antigen (rHBcAg) |
| Monoclonal |
| 1H8 |
| IgG |
| 1ug/ul |
| Purified by Protein G. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| C; Capsid protein; Core and e antigen; Core antigen; Core antigen; Core protein; HBc; HBcAg; HBVgp4; Hepatitis B Virus core antigen; p21.5; precore/core protein; CAPSD_HBVA3. |
| Hepatitis B Virus Core Antigen (HBcAg) is part of the infectious virion containing an inner "core particle" enclosing the viral genome. The icosahedral core particle contains 180 or 240 copies of the core protein. HBcAg is one of the three major clinical antigens of hepatitis B virus but disappears early in the course of infection.The hepatitis B virus core antigen (HBcAg) is a highly immunogenic subviral particle and functions as both a T-cell-dependent and a T-cell-independent antigen. Therefore, HBcAg may be a promising candidate target for therapeutic vaccine control of chronic HBV infection. |
| Application Dilution |
| IF(IHC-P) |
1:50-200 |
Powered by Bioz